Press Releases

Press Releases

October 24, 2019
BeyondSpring Announces Proposed Public Offering of Ordinary Shares
October 23, 2019
BeyondSpring Enrolls First Patient in Global Phase 3 Clinical Trial with Plinabulin in combination with G-CSF to Prevent Chemotherapy-Induced Neutropenia
October 17, 2019
BeyondSpring's Lead Asset, Plinabulin, Granted U.S. Patent Covering Methods of Treating Brain Tumors
October 8, 2019
Cell Journals Publishes BeyondSpring's New Data on Mechanism of Plinabulin to Mature Dendritic Cells, Leading to T-Cell Activation
October 1, 2019
BeyondSpring Presents Novel Trial Design for DUBLIN-3 Study BPI-2358-103 at ESMO Congress 2019
September 23, 2019
BeyondSpring's Plinabulin Continues to Build on Superior Product Profile in Breast Cancer Trial for Neutropenia Prevention
September 18, 2019
BeyondSpring Provides Operational Update and Second-Quarter 2019 Financial Results

目前在第5页, 共有5页, 共有43条记录第一页上一页 1 2 3 4 5 下一页最后一页 跳转到页

© 2020 BeyondSpring Inc. All rights reserved.